🇺🇸 FDA
Pipeline program

TRIGON DEPOT 40 mg/ml suspensión inyectable.

Phase 3 small_molecule active

Quick answer

TRIGON DEPOT 40 mg/ml suspensión inyectable. for Chronic shoulder pain is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Chronic shoulder pain
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials